StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
COCH

Envoy Medical, Inc.

COCHW Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies EDGAR ↗
$0.03
+0.00 +5.92%

Key statistics

from XBRL data in SEC filings
Market cap
$2.61M
Revenue (TTM)
$234K
Net income (TTM)
-$23.1M
EPS (TTM)
$-1.02
P/E ratio
Dividend yield
Free cash flow
-$18.4M
Cash
$25.3M
Total assets
$29.8M
Gross margin
52-week range
$0.03 – $0.03

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Terminated a material agreement Jun 30, 2026 8-K Director or officer change Jun 25, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 8-K Director or officer change; Shareholder vote results May 18, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Director or officer change Apr 21, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 13, 2026 8-K Changed accountants Mar 31, 2026 8-K Results of operations (earnings release) Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Delisting notice or listing-rule failure; Other events Feb 27, 2026 8-K Entered a material agreement; Other events Feb 13, 2026 8-K Director or officer change Feb 11, 2026 8-K Entered a material agreement Dec 29, 2025 8-K Regulation FD disclosure Dec 16, 2025 8-K Shareholder vote results Dec 3, 2025 8-K Delisting notice or listing-rule failure Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Delisting notice or listing-rule failure; Other events Oct 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 9, 2025 8-K Other events Oct 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 23, 2025 8-K Other events Sep 19, 2025 8-K Entered a material agreement Sep 9, 2025 8-K Delisting notice or listing-rule failure Aug 29, 2025 8-K Terminated a material agreement; Director or officer change Aug 26, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Entered a material agreement Jul 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 2, 2025 8-K Director or officer change Jun 25, 2025 8-K Director or officer change; Shareholder vote results Jun 3, 2025 8-K Director or officer change May 19, 2025 8-K Results of operations (earnings release) May 1, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Item 5.08 Apr 11, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025